<DOC>
	<DOCNO>NCT00282685</DOCNO>
	<brief_summary>Treatment patient diabetic neuropathy intraarterial progenitor cell transplantation .</brief_summary>
	<brief_title>Safety Feasibility Study Autologous Progenitor Cell Transplantation Diabetic Neuropathy</brief_title>
	<detailed_description>Goal : Stimulation angiogenesis induction vas nervorum order improve nerve function</detailed_description>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<criteria>Patients distal symmetrical diabetic neuropathy leg Type 1 Type 2 Diabetes Stable Glucose control last 3 month ( Hba1c &lt; 7.5 ) Written informed consent Patients peripheral arterial disease ( ABI &lt; 0.9 ) Neuropathy origin Myopathy Asymmetrical neuropathy Active infection oder fever Chronic inflammatory disease ( z.B M. Crohn , Rheumatoid Arthritis ) HIV hepatitis Neoplastic disease without complete remission within last 5 Stroke myocardial infarction within last 3 month Renal failure ( creatinine &gt; 2 mg/dl ) Liver disease ( GOT &gt; 2 upper limit spontaneous INR &gt; 1,5 ) . Anemia ( hemoglobine &lt; 8.5 mg/dl ) Platelets &lt; 100.000/Âµl HbA1c &gt; 7,5 % Allergies Aspirin , Clopidogrel , Heparin Bleeding disorder Surgery trauma within last 2 month Pregnancy Mental retardation Participation another study within 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>Patients symmetric peripheral diabetic neuropathy</keyword>
</DOC>